Coronavirus | Opeds and editorials

Only a global effort can tame COVID-19

India has been witnessing an unprecedented surge in COVID-19 cases, largely due to the new variants. The variant found initially in the United Kingdom (B.1.1.7) was found in parts of north India earlier this year and began to spread across the country. The World Health Organisation (WHO) recently declared the variant first found in India (B.1.617) as a variant of global concern as it has already spread to more than 40 countries. This underscores the fact that no one is safe until everyone is safe. It calls for globally coordinated efforts to build herd immunity through mass vaccination and to develop new vaccines or tweak the existing ones to become effective against the new variants. Experts have been doubtful about the effectiveness of some of the COVID-19 vaccines against the new variants of the virus.

Vaccine nationalism

An immediate outcome of the second wave in India is that many people are no longer hesitant to take the vaccine. However, vaccine shortages have been reported in many parts of the country. Several people have criticised the government’s Vaccine Maitri policy. The government has already imposed temporary restrictions on the export of COVID-19 vaccines from India. Although there is a need for these temporary restrictions to meet domestic demand, any definite move towards vaccine nationalism will be detrimental to global efforts to contain the virus. The pandemic needs to be checked globally in a coordinated manner. If this is not done, the virus will keep mutating and no country will remain isolated.

 

From May 1, all those aged 18 and above became eligible in India to receive the COVID-19 vaccines. This means that 595 million people who require 1,190 million doses were added to the 344 million people in the 45 and above age group requiring 688 million doses. Inoculating this huge population calls for massive production capacities. Only a little over 12% of the population has received one dose and 3.2% has received both the doses in India so far.

The current production capacity of Covishield and Covaxin is just over 70 million doses per month. The government has allocated ₹45 billion as an advance commitment to Serum Institute of India and Bharat Biotech for enhancing their production capacity. By June-July, in the best-case scenario, the combined production capacity of the two companies is expected to rise to 158 million doses per month. The 50 million imported Sputnik doses will add to this. This vaccine will be available only in major private hospitals for now. It is reported that the Sputnik vaccine will be produced in India from July with an annual capacity of 156 million doses, which, according to the Russian Ambassador to India, will be gradually increased to 850 million doses. Even if all the three vaccines are exclusively used for domestic supply, the anticipated production in the near future will not be sufficient to meet the enormous vaccine demand.

Pharmacy of the world

Being the pharmacy of the world, India needs to rise to the occasion and cater to the demand for vaccines in the country as well as facilitate inoculation of the global population, especially in poorer countries. In the first week of May, the Indian Council of Medical Research said it was willing to share the know-how to produce Covaxin with any company interested in production. Allowing multiple producers will lead to more competition and a reduction in prices. The government can easily task the public sector vaccine manufacturers with the production of Covaxin by providing support to them. In its attempt to enhance the production of Covaxin from 12.5 million doses to 58 million doses a month, the Government of India has involved three public sector enterprises — Haffkine Biopharmaceutical Corporation, Bharat Immunologicals and Biologicals Corporation Limited, and Indian Immunologicals Limited.

 

While raising an alarm on the spread of infectious diseases, a 2020 report of the WHO on the urgent health challenges for the next decade expressed concern on the lack of access to medical products, including medicines and vaccines. As infectious diseases are expected to increase in the coming years, India needs to frame a long-term strategy to enhance supply at the domestic and international level. Public sector enterprises should be an integral part of that strategy. Unfortunately, the Public Sector Enterprise Policy, released in February, has not identified public sector enterprises in the pharmaceuticals sector as strategically important, and therefore, all central public sector enterprises will subsequently be privatised.

What we need now is the mass production of COVID-19 vaccines for the mass vaccination of the global population in order for us to develop herd immunity against the virus. India still has options left for scaling up production. The National Health Profile 2019, published by the Central Bureau of Health Intelligence, Ministry of Health and Family Welfare, shows that India has an installed capacity of 8,151.7 million doses of vaccines annually, in the private and public sectors. A few of these facilities can be re-purposed for the production of COVID-19 vaccines.

International co-operation

Scaling up production of existing vaccines and producing new vaccines is not easy. Unavailability of raw materials, complexities in the transfer of technology, and intellectual property barriers all hinder production. Serum Institute and Bharat Biotech have faced constraints in continuing production due to the lack of raw materials.

 

Intellectual property rights act as a major barrier in scaling up production. About 1,800 patents cover the single-use plastic reactors which are used in the production of some of the COVID-19 vaccines. Similarly, other equipment and materials used in the production of vaccines are patent-protected and therefore supplied by only a few players. India and South Africa had led an initiative at the World Trade Organization (WTO) for the waiver of intellectual property rights over products required for treating COVID-19. Recently, after coming under pressure, the U.S. extended support to this proposal covering only vaccines. However, Germany said it is opposed to it. Therefore, it is unclear how this IP waiver proposal will help enhance the global production of vaccines. Besides, the U.S. support, which is limited to vaccines, may also limit the benefits deriving from the intellectual property waiver, if the proposal comes through the WTO.

An article published in Nature points out the benefits of mRNA vaccine technology compared to conventional vaccine technologies. The key advantage of this technology is easy scalability in production. At present, the WHO has approved two mRNA COVID-19 vaccines produced by Pfizer-BioNtech and Moderna, and those vaccines have proven to be more effective than other vaccines. Global cooperation is needed to create an environment where those companies interested in producing the mRNA vaccines get open license from the innovators.

 

Global cooperation is also required for the sequencing of the viral genome to track and control the multiple variants. Only if we tame the virus together and quickly will the world benefit both in terms of health and economy.

Reji Joseph is an Associate Professor at Institute for Studies in Industrial Development, New Delhi; Thankom Arun is a Professor of Global Development and Accountability at the University of Essex, U.K. Views are personal


Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Aug 4, 2021 7:05:31 PM | https://www.thehindu.com/opinion/op-ed/only-a-global-effort-can-tame-covid-19/article34683660.ece

In This Package
Vaccinating the young: On priority groups
A serosurvey template for the whole of India
Making decisions under stress
Dealing with denial: On playing down the COVID-19 tragedy
A cardinal omission in the COVID-19 package
Rising again: On global rise of fresh COVID-19 cases
Ramping up supply: On COVID-19 vaccination woes
Upholding trust in vaccination
Caution and optimism: On preventing the third wave
Countering the next wave of COVID-19
Stopping the surge: On unlock and the next COVID-19 wave
A welcome spike: On India’s COVID-19 vaccination record
A time to give: On ex-gratia compensation to families of COVID-19 victims
Focus on COVID-19 estimated deaths
What needs to be done with vaccines
Counting the dead: On measuring excess deaths
Refocused vaccination campaigns are possible
Bring genomic sequencing into the pandemic fight
Preparing for the next COVID-19 wave
Connecting the dots to mitigate a third wave
The red flags on the trail of the virus
Behaviorial change can reduce transmission
Adverse changes, federalism imperilled
Close the vaccination gap, in global lockstep
You are reading
Only a global effort can tame COVID-19
Addressing vaccine hesitancy
Naturally, selection: On vaccinating the vulnerable in 18+ group
Vaccination is our only weapon
Extending safety: On deferring second dose of COVID-19 vaccine
The AIDS fight offers a COVID vaccine patent pathway
The basics of an effective vaccine policy
Using all options: On Covaxin licensing
State action: On Centre’s role in COVID-19 fight
COVID mishandling foretold in the Budget
A matter of concern: On Indian coronavirus variant
Vaccine skirmishes: On production of COVID-19 vaccine
Lockdown gains: On need to augment health system
Social murder and the missing state
A CT scan for COVID merits a word of caution
To stop a third wave, India has to mask up
Is the government committed to vaccine equity?
Salutary steps: On Election Commission norms to curb COVID-19 spread
Shortage and wastage: On cutting vaccine wastage
Gasping for air, gasping for answers
Misinformed and misleading
Right priorities: On U.S. COVID-19 aid to India
A patently wrong regime
Tips for managing COVID-19 at home: the dos & don’ts
Undermining ‘vaccination for all’
Another wave spells more nutrition loss
Unfair and dangerous: On vaccine inequity
Viral load: On lockdowns, lives and livelihoods
The road ahead in India’s augmented vaccination drive
Infernal infernos: On hospital fires amid the pandemic
Too little: On the Election Commission’s COVID-19 curbs
India’s COVID crisis — when difficult became worse
A descent into disillusionment and chaos
Open and safe: On Modi government’s vaccination policy
A recipe for vaccine inequity
Vaccine diplomacy that needs specific clarifications
On the trail of the second wave’s dynamics
How can India contain the second wave?
Lessons from the first wave
Examination priorities: On annual exams amid the pandemic
The secrecy around deaths after vaccination
Indian universities need immediate vaccination
Lessons from COVID-19
The second wave: On why new COVID-19 vaccines should be cleared
Weighing in on the saga of a vaccine
Rising poverty: On pandemic-induced disparities
A booster shot for India’s vaccination plan
Allaying concerns: On public trust and vaccination programmes
A moral test: On the vaccine divide
Efficacious too: On Covaxin
Sustaining the drive: On COVID-19 vaccination phase 2
Vaccine inequities: On need to vaccinate all above 45
Addressing vaccine reluctance and policy hesitancy
Redefining the exit plan for COVID-19
Boosting confidence: On need for efficient use of COVID-19 vaccine stocks
Opening up the vaccine market
Origin and spread: On the source of SARS-CoV-2
New questions: On COVID-19 infecting one-fifth of Indian population
A year on, mind the gaps in the pandemic response
Should Board exams be conducted in one go this year?
No to vaccine nationalism, yes to global cooperation
Tempered optimism: On India’s sliding COVID-19 graph
The best shot against COVID-19
More vaccines than takers
Managing the rollout: On addressing vaccine hesitancy
Injecting confidence: On India’s COVID-19 vaccination drive
Vaccine optimism and the scientific uncertainty link
Building trust in vaccines
The debilitating side-effect of a flawed vaccine trial
Gearing up: On vaccines and public trust
A hurried gamble: On vaccines and transparency
The second dose: On COVID-19 vaccine
A constant vigil: On the new coronavirus strain in India
Unmasked, reflections on the pandemic and life
Caution pays: On Centre’s COVID-19 surveillance guidelines
Towards an effective vaccination distribution policy
Essential dry run: On COVID-19 vaccination drive
COVID-19 and limits of political accountability
The purpose of a vaccine
Clear the fog, draw up a clear vaccination policy
Rein in the vaccine nationalism, the profiteering
In vaccine race last lap, the key steps for India
The storage tale of two vaccines
T-cell immunity and COVID-19
COVID-19, climate and carbon neutrality
Signs of easing: On India’s COVID-19 fight
Has India passed the COVID-19 peak?
Sooner, better: On indigenously developed COVID-19 test kits
The battered Puja economy
Outline of a pandemic fight, by and for citizens
Pandemics and the collective consciousness
Vaccines with a global common good guarantee
Saving lives under the long shadow of the pandemic
Until vaccine: On Unlock 5
The challenge of changing health behaviour
Weighing the costs: On COVID-19 vaccine
The slow and frustrating journey of recovering from COVID-19
Health worker safety deserves a second look
Unlocking campuses: On UGC’s revised academic calendar
Recovery from COVID-19 can be a struggle
Uniting to combat COVID-19
Coronavirus fears and preconception advice
An agriculture-led revival as flawed claim
A necessary pause: On the COVID-19 vaccine race
The uncertainties over COVID-19 numbers
The challenges in counting the dead
COVID-19 deaths may be higher than reported
The many challenges in estimating deaths
Alone at the top: On India’s COVID-19 numbers
The participants we need in Phase 3 trials
Differential impact of COVID-19 and the lockdown
More than a vaccine, it is about vaccination
COVID-19 and a country club India must leave
A quest for order amid cyber insecurity
Adopting a public systems approach to COVID-19
Milestone of a million: On India’s COVID-19 numbers
Testing times: On university exams
Predictions, pandemics and public health
It’s time to flatten the pandemic stereotyping
Viral outrage only spikes the data
Sending the right message
Needed: Clear testing data
The social contract needs to be rewritten
The pandemic is about eyes shut
Joblessness and opportunity in Tamil Nadu
Green-lighting ecological decimation amidst a pandemic
COVID-19 has no religion
A case for extension: On rural jobs scheme
Surely, even if slowly: On a COVID-19 vaccine
Bend it like Italy: On flattening the COVID-19 curve
Promise and delivery: On India’s first COVID-19 vaccine
States hold the key: On Unlock 2.0
PCR testing is a double-edged sword
Science vs nonsense: On Patanjali’s COVID-19 claim
Shut and open: On tennis during the pandemic
The perils of follow the leader syndrome
The many questions about Favipiravir
In new lockdown, a second chance for Tamil Nadu
United front in Delhi: On Kejriwal government-Centre camaraderie
A prescription of equitable and effective care
Multilateralism post COVID-19
Making public transport safe during COVID-19
A better rate: On COVID-19 recovery
Look back in relief: On the migrant labour crisis
Needed, a transfusion for public health care
Wrong priorities: On keeping religious places open during a pandemic
Crossing the line: On Delhi’s decision to limit health services
Profit, not profiteering: On regulation of COVID-19 testing charges
In Persian Gulf littoral, cooperative security is key
Paging the private sector in the COVID fight
Curves and recoveries: On India’s coronavirus numbers
India’s Parliament is missing in action
Axing the economy’s trunk
Scripting a new narrative for COVID control
Open with caution: On Unlock 1
It’s time for a universal basic income programme in India
The waning of subaltern solidarity for Hindutva
Export blocks: On India’s trade amid the pandemic
A moment to trust the teacher
The echo of migrant footfalls and the silence on policy
Enjoying the fruits of their labour
Helping supply chains recover
The heavy burden of social suffering
An effective lockdown
The lockdown has highlighted stark inequalities
Will sport be the same in empty stadia?
Cinema after COVID-19
The eternal longing for the distant home
Working safely: On workplaces during the pandemic
A hole in the whole: On health sector woes
China, better prepared for the post-COVID world
How public health boosts an economy
Keep it retrospective
Backing the ‘angels in white coats’
Standstill: On opening of stadia for training
Flawed stimulus is justice denied
We need social physicians
A callous response
Peaking: On India’s coronavirus tally
Farm gate in focus: On amending Essential Commodities Act
A question of quarantine: On migrant workers and other travellers
TASMAC tribulations: On Tamil Nadu liquor sale
The pandemic and the challenge of behaviour change
One for the poor: On Centre’s corona package
Lockdown syndrome: On virus-induced economic crisis
Are India’s labour laws too restrictive?
Stop the return to laissez-faire
States cannot be left to the Centre’s mercy
Local motif: On Modi’s call for self-reliance
Liquidity lifeline: On Nirmala’s MSME package
A plan to revive a broken economy
Provide income support, restore jobs
Perilous state: On State finances
COVID-19 and the path ahead
Reaffirm cooperative federalism
Riding roughshod over State governments
Tragedy on the tracks: On the killing of 16 migrant workers
Coming to terms: On India refusing to admit community transmission
The trends shaping the post-COVID-19 world
The epidemic and ensuring safety in courts
Responding to COVID-19 at the grassroots
The face of exploitation
Contempt for labour: On dilution of labour laws
Slower growth and a tighter fiscal
Back home: On return of Indian expatriates
Blame game: On Donald Trump’s anti-China rhetoric over COVID-19
Resuscitating multilateralism with India’s help
A war-like state and a bond to the rescue
Fear and loathing in the land of the free
Everyone wants a good stimulus
Rent control amidst pandemic
Slow release: On lockdown 3.0
No comfort in numbers: On Bengal’s coronavirus cases
Pandemics without borders, South Asia’s evolution
India’s disease surveillance system needs a reboot
No relief for the nowhere people
BRICS against COVID-19
Recovering early: On India’s COVID-19 patients
It’s about food, nutrition and livelihood security
Taiwan’s coronavirus protocol shows how it is done
Needed: a pandemic patent pool
Getty Images/iStockphoto
Plasma therapy is no silver bullet
Take care of yourself too, fellow journalists
Strategic shift: On home isolation of mild coronavirus cases
Coping with today, planning for tomorrow
No end in sight: On India’s coronavirus strategy
Vividly imagining the life of migrant workers
A task for South Asia
Privacy concerns during a pandemic
Unlocking justice in the lockdown
Safe return: On migrant worker distress
The outline of another pandemic combat strategy
Pandemic and panic: On Tamil Nadu’s five-city lockdown
Protecting the poor from becoming poorer
Did SARS-CoV-2 begin from a lab?
Protection for protectors: On safety of healthcare workers
Rapid failures: On antibody testing kits
The COVID-19 paradox in South Asia
Fishing in troubled waters during a pandemic
How will India emerge out of the lockdown?
Making doctors wash hands
Locked out of cities, homes and livelihoods
Script of unity: On coronavirus and social prejudices
Exploiting a pandemic: On Trump’s immigration policy
The village is still relevant
A time for planetary solidarity
There may be no going back
No transparency in West Bengal
Focus on the curve: On India’s COVID-19 numbers
Economy in lockdown: On India’s worst case scenario
A shot of hope with a game changing vaccine
Caught in the heightened arc of communal polemics
Singing the corona tune
Helping a lending hand: On RBI’s second lockdown stimulus
A season of change: On IMD forecast system
A virus, social democracy, and dividends for Kerala
Across the gulf: On stranded Indian workers
Virtual reality: On telemedicine
A blueprint to revive the economy
A case to use JEE-Main instead of JEE-Advanced this year
Will the aviation industry recover from the pandemic?
Data-driven reporting during COVID-19
Stress test: On revised lockdown guidelines
Disastrous decision: On Trump halting funds to WHO
Cease the distractions, seize the moment
Getting the containment strategy in India right
In India’s response, a communications failure
Harmonising with nature
End the harassment of farmers now
A narrowing window: On extension of lockdown
Corona bond: On Eurozone COVID-19 rescue package
Halting the march of rumours
Polls during a pandemic
The pandemic and the contours of a health response
Economic liberalisation and its faults
Invasive, alien, most fearsome
Trade in tatters: On the global slump
Wanted, a collective national endeavour
Disingenuous and no antidote
COVID-19 and the crumbling world order
Women’s safety during lockdown
Lives and livelihoods: On economy after lockdown
Stage fright: On denying community transmission
Team India and winning the pandemic battle
In time of need: On hydroxychloroquine export
Will COVID-19 affect the course of globalisation?
Finding a scapegoat in WHO
Curating news for children during pandemic
A time for extraordinary action
For better use: On MPLADS funds
Needed, greater decentralisation of power
A key arsenal in rural India’s pandemic fight
Preparing for exit: On lifting the lockdown
Sanctions and pandemic: On America’s Iran policy
‘A script of action, responsibility and compassion’: Chief Minister Ashok Gehlot writes on Rajasthan’s fight against COVID-19
Taking a long view of the pandemic fight
Ten questions posed by the virus
A different economic approach
Why healthcare workers above 60 should be ‘benched’
Enemy at the gates: On Kerala-Karnataka border row
Reducing farm distress during a pandemic
Why everyone should wear masks
The criticality of community engagement
A niggardliness that is economically unwarranted
The spectre of a post-COVID-19 world
Light and sound: On Narendra Modi’s 9-minute light ceremony
A million and counting: On global coronavirus spread
Safe forests, safe people: On diseases of animal origin
Quarantine and the law
Making the private sector care for public health
Looking east to contain COVID-19
Limits to rugged individualism
Uncritical endorsement: On exodus of migrant workers and the Supreme Court
Beyond the blame game: On the Tablighi Jamaat episode
A long road: On India’s 21-day coronavirus lockdown
The missing notes: On politics and the fight against COVID-19
China’s zero: On China’s lead in containing coronavirus
Unprecedented step: On Wuhan lockdown
The return of the expert
Lessons from Hubei
A pandemic in an unequal India
Faith can’t override public health
Devising a people-centric response to COVID-19
Karnataka CM writes on how the State is fighting the pandemic
Tamil Nadu CM writes on how the State is stopping the pandemic in its tracks
The hunt for a cure begins with telling the truth
COVID-19 and a city’s anatomy
Long live the nation-state
The COVID cycle
Coronavirus | The worst of times, the best of times
It’s also a fight against punitive measures
The age of the neoliberal virus
The deep void in global leadership
Thinking national, acting local
Every man is a part of the main
Beyond social distancing to fight COVID-19
Next Story